150 related articles for article (PubMed ID: 35403550)
1. Systematic review and meta-analysis of C-reactive protein as a biomarker in breast cancer.
Mikkelsen MK; Lindblom NAF; Dyhl-Polk A; Juhl CB; Johansen JS; Nielsen D
Crit Rev Clin Lab Sci; 2022 Nov; 59(7):480-500. PubMed ID: 35403550
[TBL] [Abstract][Full Text] [Related]
2. A Retrospective Propensity Score Matched Study of the Preoperative C-Reactive Protein to Albumin Ratio and Prognosis in Patients with Resectable Non-Metastatic Breast Cancer.
Zhou L; Ma S; Balde AI; Han S; Cai Z; Li Z
Med Sci Monit; 2019 Jun; 25():4342-4352. PubMed ID: 31182704
[TBL] [Abstract][Full Text] [Related]
3. Prognostic role of C-reactive protein in breast cancer: a systematic review and meta-analysis.
Han Y; Mao F; Wu Y; Fu X; Zhu X; Zhou S; Zhang W; Sun Q; Zhao Y
Int J Biol Markers; 2011; 26(4):209-15. PubMed ID: 22139643
[TBL] [Abstract][Full Text] [Related]
4. C-Reactive Protein/Albumin Ratio Is an Independent Prognostic Predictor of Survival in Advanced Cancer Patients Receiving Palliative Care.
Zhang J; Zhang C; Li Q; Zhang J; Gu X; Zhao W; Chen M; Liu M; Zhang Z; Liao X; Cheng W
J Palliat Med; 2019 Dec; 22(12):1536-1545. PubMed ID: 31188054
[No Abstract] [Full Text] [Related]
5. The prognostic value of the preoperative c-reactive protein/albumin ratio in ovarian cancer.
Liu Y; Chen S; Zheng C; Ding M; Zhang L; Wang L; Xie M; Zhou J
BMC Cancer; 2017 Apr; 17(1):285. PubMed ID: 28431566
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Significance of the Preoperative Ratio of C-Reactive Protein to Albumin in Patients with Colorectal Cancer.
Shibutani M; Maeda K; Nagahara H; Iseki Y; Ikeya T; Hirakawa K
Anticancer Res; 2016 Mar; 36(3):995-1001. PubMed ID: 26976989
[TBL] [Abstract][Full Text] [Related]
7. Serum parameters as prognostic biomarkers in a real world cancer patient population treated with anti PD-1/PD-L1 therapy.
Minichsdorfer C; Gleiss A; Aretin MB; Schmidinger M; Fuereder T
Ann Med; 2022 Dec; 54(1):1339-1349. PubMed ID: 35535695
[TBL] [Abstract][Full Text] [Related]
8. Readily available biomarkers predict poor survival in metastatic pancreatic cancer.
Strijker M; van Veldhuisen E; van der Geest LG; Busch OR; Bijlsma MF; Haj Mohammad N; Homs MY; van Hooft JE; Verheij J; de Vos-Geelen J; Wilmink JW; Steyerberg WEW; Besselink MG; van Laarhoven HW;
Biomarkers; 2021 Jun; 26(4):325-334. PubMed ID: 33663300
[TBL] [Abstract][Full Text] [Related]
9. The prognostic value of C-reactive protein in renal cell carcinoma: a systematic review and meta-analysis.
Hu Q; Gou Y; Sun C; Ding W; Xu K; Gu B; Xia G; Ding Q
Urol Oncol; 2014 Jan; 32(1):50.e1-8. PubMed ID: 24239465
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of C-reactive protein in urological cancers: a systematic review and meta-analysis.
Dai J; Tang K; Xiao W; Yu G; Zeng J; Li W; Zhang YQ; Xu H; Chen ZQ; Ye ZQ
Asian Pac J Cancer Prev; 2014; 15(8):3369-75. PubMed ID: 24870724
[TBL] [Abstract][Full Text] [Related]
11. Elevated biomarkers of inflammation are associated with reduced survival among breast cancer patients.
Pierce BL; Ballard-Barbash R; Bernstein L; Baumgartner RN; Neuhouser ML; Wener MH; Baumgartner KB; Gilliland FD; Sorensen BE; McTiernan A; Ulrich CM
J Clin Oncol; 2009 Jul; 27(21):3437-44. PubMed ID: 19470939
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the Glasgow Prognostic Score (GPS) and the modified Glasgow Prognostic Score (mGPS) in evaluating the prognosis of patients with operable and inoperable non-small cell lung cancer.
Fan H; Shao ZY; Xiao YY; Xie ZH; Chen W; Xie H; Qin GY; Zhao NQ
J Cancer Res Clin Oncol; 2016 Jun; 142(6):1285-97. PubMed ID: 26864695
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of an inflammation-based prognostic score (GPS) in patients with metastatic breast cancer.
Al Murri AM; Bartlett JM; Canney PA; Doughty JC; Wilson C; McMillan DC
Br J Cancer; 2006 Jan; 94(2):227-30. PubMed ID: 16404432
[TBL] [Abstract][Full Text] [Related]
14. C-Reactive Protein as a Prognostic Biomarker for Gynecologic Cancers: A Meta-Analysis.
Yang Y; Li X; Qian H; Di G; Zhou R; Dong Y; Chen W; Ren Q
Comput Intell Neurosci; 2022; 2022():6833078. PubMed ID: 36268143
[TBL] [Abstract][Full Text] [Related]
15. Significance of Markers of Systemic Inflammation for Predicting Survival and Chemotherapeutic Outcomes and Monitoring Tumor Progression in Patients with Unresectable Metastatic Colorectal Cancer.
Shibutani M; Maeda K; Nagahara H; Ohtani H; Sakurai K; Yamazoe A; Kimura K; Toyokawa T; Amano R; Kubo N; Tanaka H; Muguruma K; Ohira M; Hirakawa K
Anticancer Res; 2015 Sep; 35(9):5037-46. PubMed ID: 26254405
[TBL] [Abstract][Full Text] [Related]
16. Association between preoperative C-reactive protein level and colorectal cancer survival: a meta-analysis.
Woo HD; Kim K; Kim J
Cancer Causes Control; 2015 Nov; 26(11):1661-70. PubMed ID: 26376895
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of C-reactive protein in esophageal cancer: a meta-analysis.
Zheng TL; Cao K; Liang C; Zhang K; Guo HZ; Li DP; Zhao S
Asian Pac J Cancer Prev; 2014; 15(19):8075-81. PubMed ID: 25338987
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of preoperative C-reactive protein: albumin ratio in patients with clear cell renal cell carcinoma.
Chen Z; Shao Y; Fan M; Zhuang Q; Wang K; Cao W; Xu X; He X
Int J Clin Exp Pathol; 2015; 8(11):14893-900. PubMed ID: 26823819
[TBL] [Abstract][Full Text] [Related]
19. A Novel Inflammation-Based Stage (I Stage) Predicts Overall Survival of Patients with Nasopharyngeal Carcinoma.
Li JP; Chen SL; Liu XM; He X; Xing S; Liu YJ; Lin YH; Liu WL
Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27854304
[TBL] [Abstract][Full Text] [Related]
20. Prognostic role of C-reactive protein in prostate cancer: a systematic review and meta-analysis.
Liu ZQ; Chu L; Fang JM; Zhang X; Zhao HX; Chen YJ; Xu Q
Asian J Androl; 2014; 16(3):467-71. PubMed ID: 24589465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
